Intake of 5-ARIs for BPH not associated with increased mortality in prostate cancer Dr. Kamal Kant Kohli7 Jun 2022 2:00 PM GMTResearchers have found in a new study that Intake of 5-ARIs for BPH is not associated with increased mortality in prostate cancer. The study has been...
Women with big breasts have safer RT in prone position than supine position; JAMA Medical Dialogues Editorial Team30 May 2022 8:00 AM GMTA new study published in the Journal of American Medical Association suggests that treatment in the prone posture reduces desquamation in women...
Less skin toxicity in big-breasted women treated for breast cancer by radiotherapy in prone position Isra Zaman30 May 2022 4:00 AM GMTTreatment in the prone position decreases desquamation in women with large breast sizes receiving adjuvant radiotherapy, according to the recent...
First Mutation-Targeted Bladder Cancer Drug May Be Under-Used Dr. Kamal Kant Kohli19 May 2022 2:30 PM GMT PHILADELPHIA: The first bladder cancer drug targeting a cancer-driving gene mutation has been used relatively little despite its clear efficacy...
Is Etirinotecan Pegol better than chemotherapy in treating Brain Metastases? Medical Dialogues Editorial Team15 May 2022 4:00 PM GMTThe findings of the ATTAIN randomized clinical study, published in the Journal of the American Medical Association, showed no statistical difference...
Early screening with endoscopy for colorectal cancer lowers incident risk: JAMA Medical Dialogues Editorial Team9 May 2022 4:00 AM GMTUSA: In a new study conducted by Wenjie Ma and the team, it was shown that beginning endoscopy before the age of 50 was related to a lower risk of...
Lifetime obesity shows increased impact in Colorectal Cancer risk: JAMA Medical Dialogues Editorial Team8 April 2022 3:30 AM GMTA new study shows a higher role for cumulative lifetime excess weight in colorectal cancer (CRC) risk than previous studies based on single-point BMI...
Screening MRI may reduce breast cancer mortality in high-risk women: JAMA Medha Baranwal26 March 2022 3:30 AM GMTUSA: A modeling analysis suggests that in women with ATM, CHEK2, and PALB2 pathogenic variants, annual MRI screening starting at 30 to 35 years of age ...
MRI may lower breast cancer deaths from variants in 3 genes Hina Zahid15 March 2022 3:30 AM GMTAnnual MRI screenings starting at ages 30 to 35 may reduce breast-cancer mortality by more than 50% among women who carry certain genetic changes in...
Extensive Sedentary behavior impacts post-cancer survival for the worst; JAMA Medical Dialogues Editorial Team13 Jan 2022 3:30 AM GMTAccording to a new study, the combination of extended sitting and lack of physical exercise is quite common and is connected with the highest chances...
Aptinib shows increased overall survival in Patients with Thyroid Cancer: JAMA Medical Dialogues Editorial Team28 Dec 2021 3:30 AM GMTApatinib showed substantial therapeutic advantages in both extended Progression Free Survival (PFS) and overall survival with a tolerable safety...
Autoimmune gastritis the driving factor in Young women towards Gastric Cancer: JAMA MD Editorial Team23 Dec 2021 3:30 AM GMTAutoimmune gastritis is another possible cause of stomach cancer. With the decreasing frequency of chronic Helicobacter pylori infection, this reason...
